HEATHER SIMMONS FUTRELL: Open Payments
NPI 1689297715 · ROCKINGHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,218 in 126 payments from 20 companies in 2025. Trend: 2023 $1,764 · 2024 $1,772 · 2025 $2,218
Food & beverage: $2,218
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $594 |
| Vanda Pharmaceuticals Inc. | 14 | $263 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $211 |
| Amgen Inc. | 10 | $164 |
| Supernus Pharmaceuticals, Inc. | 10 | $153 |
| Indivior Inc. | 6 | $141 |
| Otsuka America Pharmaceutical, Inc. | 8 | $138 |
| Collegium Pharmaceutical, Inc. | 5 | $99 |
| Lundbeck LLC | 3 | $67 |
| Axsome Therapeutics, Inc. | 4 | $66 |
Products named: VRAYLAR, FANAPT, CAPLYTA, REXULTI, Qelbree, SUBLOCADE, REPATHA, Jornay PM.
Industry payments across NC — which companies pay providers there.
